Selzentry (Generic Maraviroc): Complete Medication Guide
Key Takeaways
Maraviroc is an HIV medication that blocks the CCR5 protein, preventing the virus from entering CD4+ cells
It's used as part of combination antiretroviral therapy for treatment-experienced patients with CCR5-tropic HIV
Common side effects include cough, fever, and upper respiratory infections
Must be taken exactly as prescribed; missing doses can lead to drug resistance
Regular monitoring with a healthcare provider is essential for treatment success
Selzentry (Generic Maraviroc) Overview
Maraviroc is an antiretroviral medication belonging to a class of drugs called CCR5 antagonists. It works by blocking the CCR5 receptor on the surface of CD4+ T cells, preventing HIV from entering and infecting these immune cells. This mechanism makes it unique among HIV treatments, as it targets the virus's entry point rather than its replication process.
The CCR5 receptor functions like a lock on the surface of immune cells. HIV uses this receptor as one of its primary entry points to infect CD4+ T cells, which are critical soldiers in your body's immune system. By blocking this receptor with maraviroc, the medication prevents the virus from gaining access to these cells, effectively stopping the infection before it can begin. This is fundamentally different from other HIV medications that work after the virus has already entered the cell.
Generic maraviroc offers the same active ingredient as the brand-name Selzentry at a significantly lower cost. Generic vs Brand Name Drugs provide identical therapeutic benefits while making treatment more affordable and accessible. The generic formulation undergoes the same rigorous testing and quality control as the brand-name version, ensuring you receive the same medication quality and effectiveness at a fraction of the price.
Maraviroc is primarily prescribed for treatment-experienced patients with CCR5-tropic HIV-1 infection. This means the medication is typically reserved for people whose HIV virus specifically uses the CCR5 receptor to enter cells, which can be determined through tropism testing. Before starting maraviroc, your doctor will perform blood tests to confirm your virus type. The medication must always be combined with other antiretroviral medications as part of a comprehensive treatment regimen. The drug is typically used when patients have developed resistance to other HIV medications or when standard first-line treatments haven't worked effectively. Your healthcare provider will determine whether maraviroc is appropriate for your specific situation based on viral tropism testing, your treatment history, and your overall health profile. Starting maraviroc usually indicates you've faced challenges with previous HIV regimens, making this medication an important option for reclaiming control of your viral load.
Side Effects
Maraviroc is generally well-tolerated, but like all medications, it may cause side effects in some people. Most side effects are mild to moderate and tend to improve as your body adjusts to the medication over the first few weeks of treatment.
Common Side Effects
Cough – A dry or mild cough that may persist throughout treatment, similar to a lingering cold. This occurs in roughly 10-15% of patients and usually doesn't require stopping the medication.
Fever – Occasional low-grade fever, especially in the first weeks of therapy. This typically resolves on its own as your immune system adapts to the medication.
Upper respiratory infections – Increased susceptibility to common colds and sinus infections. Your immune system may be more vulnerable while adjusting to treatment, though this generally improves over time.
Diarrhea or abdominal pain – Mild gastrointestinal discomfort that usually improves over time. Taking the medication with food may help reduce stomach upset.
Dizziness or headache – Lightheadedness or mild headaches that typically subside within a few days or weeks. Staying hydrated and avoiding sudden position changes can help manage dizziness.
Rash – Skin irritation or mild rash in some patients. This is usually harmless and fades without treatment, though inform your doctor if it worsens or spreads.
Serious Side Effects
Hepatotoxicity (liver damage) – Elevated liver enzymes or liver injury, particularly in patients with hepatitis B or C. Your liver must process maraviroc, making regular liver function tests essential during treatment.
Orthostatic hypotension – Sudden drops in blood pressure when standing up, potentially causing fainting. This happens because maraviroc can affect blood vessel function in some patients, requiring careful monitoring especially when first starting the medication or adjusting doses.
Severe allergic reactions – Rare but serious reactions including Stevens-Johnson syndrome or angioedema. These reactions can develop suddenly and require immediate emergency medical attention.
Cardiovascular events – Increased risk of heart attack or stroke in some populations. Studies have shown maraviroc may carry slightly elevated cardiovascular risks, particularly in patients with existing heart disease or risk factors.
Immune reconstitution inflammatory syndrome (IRIS) – Inflammatory response when the immune system rapidly recovers. As HIV is controlled and CD4 counts rise, your newly strengthened immune system may overreact to infections you previously had, causing unexpected inflammation and symptoms.
When to Seek Medical Attention
Contact your healthcare provider immediately if you experience severe allergic reactions, difficulty breathing, chest pain, sudden dizziness, or signs of liver problems such as yellowing skin or eyes, dark urine, or persistent abdominal pain. If you notice unusual bruising, severe rash, or signs of infection that don't improve, seek medical attention promptly. These symptoms may indicate serious complications requiring immediate evaluation and treatment adjustment. Never ignore warning signs, as early intervention can prevent complications from becoming severe and irreversible.
Dosage
Dose Level or Form |
Standard Dose |
Important Details |
Tablets (standard formulation) |
300 mg twice daily |
Used with most antiretroviral combinations |
Tablets (with CYP3A inhibitors) |
150 mg twice daily |
Lower dose when taking protease inhibitors or certain other drugs |
Tablets (with CYP3A inducers) |
600 mg twice daily |
Higher dose when taking rifampin or other enzyme-inducing drugs |
Pediatric patients |
Dosing varies by weight |
Child-specific tablets available; consult prescribing information |
Drug Interactions
Maraviroc interacts with several medications because it's metabolized by liver enzymes. Understanding these interactions is crucial for safe and effective treatment. Your liver uses specific enzyme systems to break down maraviroc, and other medications can either interfere with or enhance this process, changing how much active drug remains in your body.
Protease Inhibitors (Ritonavir, Lopinavir)
These HIV medications inhibit the same liver enzymes that break down maraviroc, causing the drug to accumulate in your system at higher levels than intended. Your maraviroc dose must be reduced to 150 mg twice daily to prevent toxicity. Without this adjustment, you could experience dangerous levels of the medication in your blood.
Rifampin (Tuberculosis Treatment)
Rifampin significantly increases the breakdown of maraviroc, reducing its effectiveness to dangerous levels. If you need rifampin, your maraviroc dose must be increased to 600 mg twice daily, or alternative TB medications should be considered. This interaction is serious because untreated tuberculosis can be life-threatening for HIV patients.
St. John's Wort (Herbal Supplement)
This herbal supplement dramatically reduces maraviroc levels by increasing its metabolism. Avoid St. John's Wort entirely during maraviroc treatment, as it may cause treatment failure and allow your viral load to rebound dangerously.
Certain Antifungal Medications (Ketoconazole, Itraconazole)
These antifungals slow maraviroc metabolism, potentially increasing drug levels in your bloodstream. Your dose may need adjustment, or your doctor may recommend alternative antifungal options that don't interact as strongly with maraviroc.
NRTIs (Nucleoside Reverse Transcriptase Inhibitors)
Most NRTIs like lamivudine and emtricitabine don't directly interact with maraviroc but are commonly combined with it as part of standard HIV therapy. These combinations are generally safe and effective, with NRTIs working through different mechanisms than maraviroc.
Continue Learning
Related articles you might find helpful
Pros and Cons
Pros
Unique mechanism of action – Blocks HIV entry rather than replication, offering an alternative for resistant strains that have adapted to other drug classes
Oral tablet form – Easy to take compared to injections or infusions, improving medication adherence and quality of life
Well-tolerated – Most common side effects are mild and manageable, with many improving over time as your body adjusts
Affordable generic option – Cost-Effective Alternative to Brand-Name Drugs makes treatment more accessible and reduces financial burden
Effective for treatment-experienced patients – Provides options when other HIV drugs have failed, potentially giving you a second chance at viral control
Cons
Requires tropism testing – Not suitable for everyone; virus type must be confirmed first through additional blood tests
Complex dosing adjustments – Interactions with other medications require careful dose management and ongoing medication review
Potential liver complications – Requires regular monitoring in patients with hepatitis B or C, adding to treatment complexity
Cardiovascular risk – May increase heart attack or stroke risk in certain populations, particularly those with existing heart disease
Must be combined with other drugs – Cannot be used as monotherapy; requires complete HIV regimen for effectiveness and to prevent resistance
Frequently Asked Questions
Maraviroc is a CCR5 antagonist that blocks the entry point for HIV rather than inhibiting viral replication. Other HIV drugs like NRTIs and protease inhibitors work differently by stopping the virus from copying itself inside the cell. This unique mechanism makes maraviroc valuable for patients whose virus has developed resistance to other drug classes, offering a completely different approach to controlling HIV.
Maraviroc can be used with hepatitis B, but requires close monitoring. Your liver function must be tested regularly because both HIV and hepatitis B can cause liver damage. If you have hepatitis B, stopping maraviroc suddenly can cause severe hepatitis flares, so treatment must be managed carefully by your healthcare provider who understands coinfection complications.
Take the missed dose as soon as you remember, unless it's almost time for your next dose. Never double up on doses to make up for a missed one. Missing doses regularly increases the risk of drug resistance, which could make maraviroc and potentially other HIV medications less effective over time, limiting your future treatment options.
Yes, generic maraviroc contains the identical active ingredient and provides the same therapeutic benefit as brand-name Selzentry. Generic vs. Brand-Name Drugs undergo rigorous FDA testing to ensure they're bioequivalent, meaning your body processes them the same way and experiences the same medication effects.
Your healthcare provider will typically recommend regular blood tests to monitor CD4 count, viral load, and liver function. Most patients require testing every 3 to 6 months, but frequency may increase if you have hepatitis coinfection or other complications. Regular monitoring ensures your treatment is working and side effects are being managed safely.
The Bottom Line
Maraviroc is an effective antiretroviral medication that offers a unique approach to HIV treatment by blocking viral entry. As a generic option, it provides the same benefits as brand-name Selzentry at a lower cost, making HIV therapy more accessible. Success with maraviroc requires consistent adherence, regular medical monitoring, and careful management of drug interactions. This information is educational and does not replace advice from your healthcare provider. At Doctronic, we're committed to helping you navigate HIV treatment options. As the first AI legally authorized to practice medicine, we've supported 22 million consultations with a 99.2% treatment alignment rate with physicians. Get answers to your HIV medication questions through free AI consultations, $39 video visits, or $19 text consultations available 24/7 with just a 4-minute wait. Ready to take control of your health? Get started with Doctronic today.
